These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27374996)

  • 1. The effectiveness of neurofeedback on cognitive functioning in patients with Alzheimer's disease: Preliminary results.
    Luijmes RE; Pouwels S; Boonman J
    Neurophysiol Clin; 2016 Jun; 46(3):179-87. PubMed ID: 27374996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial.
    Marlats F; Djabelkhir-Jemmi L; Azabou E; Boubaya M; Pouwels S; Rigaud AS
    Trials; 2019 Jan; 20(1):88. PubMed ID: 30696475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Modulation of Gamma-Band Synchronization through EEG-Neurofeedback Training in the Elderly.
    Andrade K; Houmani N; Guieysse T; Razafimahatratra S; Klarsfeld A; Dreyfus G; Dubois B; Vialatte F; Medani T
    J Integr Neurosci; 2024 Mar; 23(3):67. PubMed ID: 38538229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative EEG Neurometric Analysis-Guided Neurofeedback Treatment in Dementia: 20 Cases. How Neurometric Analysis Is Important for the Treatment of Dementia and as a Biomarker?
    Surmeli T; Eralp E; Mustafazade I; Kos H; Özer GE; Surmeli OH
    Clin EEG Neurosci; 2016 Apr; 47(2):118-33. PubMed ID: 26099949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative EEG in Alzheimer's disease: cognitive state, resting state and association with disease severity.
    Garn H; Waser M; Deistler M; Schmidt R; Dal-Bianco P; Ransmayr G; Zeitlhofer J; Schmidt H; Seiler S; Sanin G; Caravias G; Santer P; Grossegger D; Fruehwirt W; Benke T
    Int J Psychophysiol; 2014 Sep; 93(3):390-7. PubMed ID: 24933410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofeedback in healthy elderly human subjects with electroencephalographic risk for cognitive disorder.
    Becerra J; Fernández T; Roca-Stappung M; Díaz-Comas L; Galán L; Bosch J; Espino M; Moreno AJ; Harmony T
    J Alzheimers Dis; 2012; 28(2):357-67. PubMed ID: 22002790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta and gamma neurofeedback on memory and intelligence in the elderly.
    Staufenbiel SM; Brouwer AM; Keizer AW; van Wouwe NC
    Biol Psychol; 2014 Jan; 95():74-85. PubMed ID: 23751914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantified electroencephalographic correlates of neuropsychological deficits in Alzheimer's disease.
    Pozzi D; Petracchi M; Sabe L; Golimstock A; García H; Starkstein S
    J Neuropsychiatry Clin Neurosci; 1995; 7(1):61-7. PubMed ID: 7711494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific or nonspecific? Evaluation of band, baseline, and cognitive specificity of sensorimotor rhythm- and gamma-based neurofeedback.
    Kober SE; Witte M; Neuper C; Wood G
    Int J Psychophysiol; 2017 Oct; 120():1-13. PubMed ID: 28652143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review.
    Berman MH; Nichols TW
    Photobiomodul Photomed Laser Surg; 2019 Oct; 37(10):623-634. PubMed ID: 31647776
    [No Abstract]   [Full Text] [Related]  

  • 11. Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy.
    Barban F; Annicchiarico R; Pantelopoulos S; Federici A; Perri R; Fadda L; Carlesimo GA; Ricci C; Giuli S; Scalici F; Turchetta CS; Adriano F; Lombardi MG; Zaccarelli C; Cirillo G; Passuti S; Mattarelli P; Lymperopoulou O; Sakka P; Ntanasi E; Moliner R; Garcia-Palacios A; Caltagirone C
    Int J Geriatr Psychiatry; 2016 Apr; 31(4):340-8. PubMed ID: 26205305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofeedback Improves Memory and Peak Alpha Frequency in Individuals with Mild Cognitive Impairment.
    Lavy Y; Dwolatzky T; Kaplan Z; Guez J; Todder D
    Appl Psychophysiol Biofeedback; 2019 Mar; 44(1):41-49. PubMed ID: 30284663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of quantitative electroencephalography and current source density in patients with Alzheimer's disease.
    Kim JS; Lee SH; Park G; Kim S; Bae SM; Kim DW; Im CH
    Brain Topogr; 2012 Oct; 25(4):461-74. PubMed ID: 22736322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a community-based multidomain cognitive intervention program in patients with Alzheimer's disease.
    Kim HJ; Yang Y; Oh JG; Oh S; Choi H; Kim KH; Kim SH
    Geriatr Gerontol Int; 2016 Feb; 16(2):191-9. PubMed ID: 25656505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial.
    Trebbastoni A; Imbriano L; Podda L; Rendace L; Sacchetti ML; Campanelli A; D'Antonio F; de Lena C
    Curr Alzheimer Res; 2018 Mar; 15(5):452-461. PubMed ID: 29141548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG correlates in the spectrum of cognitive decline.
    van der Hiele K; Vein AA; Reijntjes RH; Westendorp RG; Bollen EL; van Buchem MA; van Dijk JG; Middelkoop HA
    Clin Neurophysiol; 2007 Sep; 118(9):1931-9. PubMed ID: 17604688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological correlates of the P300 in patients with Alzheimer's disease.
    Lee MS; Lee SH; Moon EO; Moon YJ; Kim S; Kim SH; Jung IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():62-9. PubMed ID: 22940475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.